Antimicrobial stewardship programs: Interventions and associated outcomes

Expert Review of Anti-Infective Therapy

Volumn 6, Issue 2, 2008, Pages 209-222

  Patel, Dimple ^a   Lawson, Wendy ^b   Guglielmo, B Joseph ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

Adverse reaction; Antimicrobial stewardship; Cost; Outcome; Resistance; Superinfection

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN; AMPHOTERICIN B; ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEPHALOSPORIN; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; GENTAMICIN; GLYCOPEPTIDE; IMIPENEM; LEVOFLOXACIN; LINEZOLID; METICILLIN; OXACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TIMENTIN; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; CLOSTRIDIUM DIFFICILE; COLITIS; COST CONTROL; DRUG COST; HEALTH CARE COST; HEALTH PROGRAM; HOSPITAL INFECTION; HUMAN; INFECTION; INFECTION PREVENTION; MEDICAL AUDIT; MEDICAL EDUCATION; MEDICAL SPECIALIST; MULTIDRUG RESISTANCE; NEPHROTOXICITY; NONHUMAN; OTOTOXICITY; OUTCOME ASSESSMENT; PNEUMONIA; PRACTICE GUIDELINE; REVIEW; SUPERINFECTION; TEAMWORK; UNSPECIFIED SIDE EFFECT; DRUG UTILIZATION; HEALTH CARE PERSONNEL; HOSPITAL MANAGEMENT; PHARMACIST;

ANTI-BACTERIAL AGENTS; DRUG UTILIZATION; HOSPITAL ADMINISTRATION; HUMANS; INFECTION CONTROL PRACTITIONERS; PHARMACISTS; PRACTICE GUIDELINES AS TOPIC;

EID: 45549104993     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.6.2.209     Document Type: Review

References (42)

1. Dellit TH, Owens RC, McGowan JE Jr et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin. Infect. Dis. 44(2), 159-177 (2007).
2. MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin. Micro. Rev. 18(4), 638-656 (2005).
3. Fishman N. Antimicrobial stewardship. Am. J. Med. 119(6A), S53-S61 (2006).
4. Davey P, Brown E, Fenelon L et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database of Syst. Rev. 4, CD003543 (2005).
5. Berild D, Ringertz SH, Aabyholm G, Lelek M, Fosse B. Impact of an antibiotic policy ou antibiotic use in a paediatric department. Individual based follow-up shows that antibiotics were chosen according to diagnoses and bacterial findings. Int. J. Antimicrob. Agents. 20(5), 333-338 (2002).
6. Kuti JL, Le TH, Nightingale CH, Nicolau DP, Quintiliani R. Pharmacocconomics of a pharmacist- managed program for automatically converting levofloxacin route from i.v. to oral. Am. J. Health-Syst. Pharm. 59(22), 2209-2215 (2002).
7. Ansari F, Gray K, Nathwani D et al. Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. J. Antimicrob. Chemother. 52(5), 842-848 (2003).
8. Bantar C, Sartori B, Vesco E et al. A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin. Infect. Dis. 37(2), 180-186 (2003).
9. Cannon JP, Silverman RM. A pharmacist-driven antimicrobial approval program at a veterans affairs hospital. Am. J. Health Syst. Pharm. 60(13), 1358-1362 (2003).
10. Carling P, Fung T, Killion A, Terrin N, Barza M. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect. Control Hosp. Epidemiol. 24(9), 699-706 (2003).
11. dos Santos EF, Silva AE, Pinhati HM, Maia Mde O. Effectiveness of the actions of antimicrobial's control in the intensive care unit. Braz. J. Infect. Dis. 7(5), 290-296 (2003).
12. Feucht CL, Rice LB. An interventional program to improve antibiotic use. Ann. Pharmacother. 37(5), 646-651 (2003).
13. Geissler A, Gerbeuax P, Granier I, Blanc P, Facon K, Durand-Gasselin J. Rational use of antibiotics in the intensive care unit: impact on microbial resistance and costs. Intensive Care Med. 29(1), 49-54 (2003).
14. Glowacki RC, Schwartz DN, Itokazu GS, Wisniewski MF, Kieszkowski P, Weinstein RA. Antibiotic combinations with redundant antimicrobial spectra: clinical epidemiology and pilot intervention of computer-assisted surveillance. Clin. Infect. Dis. 37(1), 59-64 (2003).
15. LaRocco A. Concurrent antibiotic review programs - a role for infectious diseases specialists at small community hospitals. Clin. Infect. Dis. 37(5), 742-743 (2003).
16. Saizy-Callaert S, Causse R, Furhman C, Le Paih MF, Thebault A, Chouaid C. Impact of a multidisciplinary approach to the control of antibiotic prescription in a general hospital. J. Hosp. Infect. 53(3), 177-182 (2003).
17. South M, Royle J, Starr M. A simple intervention to improve hospital antibiotic prescribing. Med. J. Aust. 178(5), 207-209 (2003).
18. von Gunten V, Amos V, Sidler AL, Beney J, Troillet N, Reymond JP. Hospital pharmacists' reinforcement of guidelines for switching from parenteral to oral antibiotics: a pilot study. Pharm. World Sci. 25(2), 52-55 (2003).
19. Cook PP, Catrou PG, Christie JD, Young PD, Polk RE. Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram. J. Antimicrob. Chemother. 53(5), 853-859 (2004).
20. Lutters M, Harbarth S, Janssens JP et al. Effect of a comprehensive, multidisciplinary, educational program on the use of antibiotics in a geriatric university hospital. J. Am. Geriatr. Soc. 52(1), 112-116 (2004).
21. Ruttimann S, Keck B, Hartmeier C, Maetzel A, Bucher HC. Long-term antibiotic cost savings from a comprehensive intervention program in a medical department of a university-affiliated teaching hospital. Clin. Infect. Dis. 38(3), 348-356 (2004).
22. Bruno-Murtha LA, Brusdi J, Bor D, Li W, Zucker D. A pilot study of antibiotic cycling in the community hospital setting. Infect. Control Hosp. Epidemiol. 26(1), 81-87 (2005).
23. Davis SL, Delgado G, McKinnon PS. Pharmacoeconomic considerations associated with use of intravenous-to-oral moxifloxacin for community-acquired pneumonia. Clin. Infect. Dis. 41(Suppl. 2), S136-S143 (2005).
24. Martin C, Ofotokun I, Rapp R et al. Results of an antimicrobial control program at a university hospital. Am. J. Health Syst. Pharm. 62(7), 732-738 (2005).
25. Apisamthanarak A, Danchaivijitr S, Khawcharoenporn T et al. Effectiveness of education and an antibiotic-control program in a tertiary care hospital in Thailand. Clin. Infect. Dis. 42(6), 768-775 (2006).
26. Arnold FW, McDonald C, Smith S, Newman D, Ramirez JA. Improving antimicrobial use in the hospital setting by providing usage feedback to prescribing physicians. Infect. Control Hosp. Epidemiol. 27(4), 378-382 (2006).
27. Gomez MI, Acosta-Gnass SI, Mosqueda-Barbou L, Basualdo JA. Reduction in surgical antibiotic prophylaxis expenditure and the rate of surgical site infection by means of a protocol that controls the use of prophylaxis. Infect. Control Hosp. Epidemiol. 27(12), 1358-1365 (2006).
28. McGregor JC, Weekes E, Forrest GN et al. Impact of a computerized clinical decision support system on reducing inappropriate antimicrobial use: a randomized controlled trial. J. Am. Med. Inform. Assoc. 13(4), 378-384 (2006).
29. Philmon C, Smith T, Williamson S, Goodman E. Controlling use of antimicrobials in a community teaching hospital. Infect. Control Hosp. Epidemiol. 27(3), 239-244 (2006).
30. Schwartzberg E, Rubinovich S, Hassin D et al. Developing and implementing a model for changing physicians' prescribing habits - the role of clinical pharmacy in leading the change. J. Clin. Pharm. Ther. 31(2), 179-185 (2006).
31. Zahar JR, Rioux C, Girou E et al. Inappropriate prescribing of aminoglycosides: risk factors and impact of an antibiotic control team. J. Antimicrob. Chemother. 58(3), 651-656 (2006).
32. Mach R, Vlcek J, Prusova M, Batka P, Rysavy V, Kubena A. Impact of a multidisciplinary approach on antibiotic consumption, cost, and microbial resistance in a Czech hospital. Pharm. World Sci. 29(5), 565-572 (2007).
33. Meyer E, Buttler J, Schneider C et al. Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced. J. Antimicrob. Chemother. 59(6), 1148-1154 (2007).
34. Khan R, Cheesbrough J. Impact of changes in antbiotic policy on Clostridium difficile- associated diarrhoea (CDAD) over a five-year period in a district general hospital. J. Hosp. Infect. 54(2), 104-108 (2003).
35. Lautenbach E, LaRosa LA, Mart AM, Nachamkin I, Bilker WB, Fishman NO. Changes in the prevalence of vancomycin- resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins. Clin. Infect. Dis. 36(4), 440-446 (2003).
36. O'Connor KA, Kingston M, O'Donovan M, Cryan B, Twomey C, O'Mahony D. Antibiotic prescribing policy and Clostridium difficle diarrhoea. Q. J. Med. 97(7), 423-429 (2004).
37. Guglielmo BJ, Dudas V, Maewal I et al. Impact of a series of interventions in vancomycin prescribing on use and prevalence of vancomycin-resistant enterococci. Jt Comm. J. Qual. Patient Saf. 31(8), 469-475 (2005).
38. Chang MT, Wa TH, Wang CY, Jang TN, Huang CY. The impact of an intensive antimicrobial control program in a Taiwanese medical center. Pharm.World Sci. 28(4), 257-264 (2006).
39. Fowler S, Webber A, Cooper BS et al. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series. J. Antimicrob. Chemother. 59(5), 990-995 (2007).
40. Valiquette L, Cossette B, Garant MP Diab H, Pepin J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficle-associated disease caused by the hypervirulent NAP1/027 strain. Clin. Infect. Dis. 45(Suppl. 2), S112-S121 (2007).
41. Muto CA, Blank MK, Marsh JW et al. Control of an outbreak of infection with the hypervirulent. Clostriudium difficle BI strain in a university hospital using a comprehensive "bundle" approach. Clin. Infect. Dis. 45(10), 1266-1273 (2007).
42. Giblin TB, Sinkowitz-Cochran RL, Harris PL et al. Clinician's perceptions of die problem of antimicrobial resistance in health care facilities. Arch. Intern. Med. 164(15), 1662-1668 (2004).